TI
TAK icon

tru Independence’s Takeda Pharmaceutical TAK Stock Holding History

tru Independence’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-245
Closed -$4 – 795
2020
Q2 		$4 Sell
245
-150
-38% -$2.69K ﹤0.01% 748
2020
Q1 		$6 Hold
395
– – ﹤0.01% 511
2019
Q4 		$6K Buy
+395
New +$7.56K ﹤0.01% 656

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

tru Independence's TAK Position: Q3 2020 in Review

tru Independence sold out of Takeda Pharmaceutical (TAK) in Q3 2020, closing a stake of 245 shares — an estimated $4 sold.

tru Independence first reported a position in TAK in Q4 2019 and held it in 3 quarters. The position peaked at $6K in Q4 2019. 310 funds tracked by Wall St. Rank hold TAK as of Q3 2020.

  • tru Independence reported no remaining Takeda Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • tru Independence sold 245 Takeda Pharmaceutical shares in Q3 2020, an estimated $4.
  • tru Independence first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 3 quarters.
  • tru Independence's Takeda Pharmaceutical position peaked at $6K in Q4 2019.
  • 310 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.